Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cost-Utility of Conventional Hemodialysis (CHD) Vs Short Daily Hemodialysis (SDHD) for Patients Coming From Peritoneal Dialysis (HAPD/CAPD): A Randomized Controlled Trial

NCT02002949 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari as lead sponsor.

NCT NCT02002949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02002949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cost-Utility of Conventional Hemodialysis (CHD) Vs Short Daily Hemodialysis (SDHD) for Patients Coming From Peritoneal Dialysis (HAPD/CAPD): A Randomized Controlled Trial
Lead sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2014
Completion date
December 31, 2017
Enrollment
144 (estimated)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease